Skip to main content
Top
Published in: International Journal of Clinical Oncology 1/2015

01-02-2015 | Original Article

Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy

Authors: Masatomo Nishikawa, Hideaki Miyake, Kazuhiro Kitajima, Satoru Takahashi, Kazuro Sugimura, Masato Fujisawa

Published in: International Journal of Clinical Oncology | Issue 1/2015

Login to get access

Abstract

Background

The aim of this study is to accurately differentiate between benign and malignant small renal masses (SRMs) prior to surgery.

Methods

The study included 144 patients with SRMs <4 cm suspected to be renal cell carcinoma (RCC) based on several imaging examinations, who subsequently underwent partial nephrectomy. Clinicopathological data were analyzed based on the preoperative findings obtained from enhanced computed tomography (CT) as follows: group 1 showing a typical imaging pattern for clear cell RCC (CCRCC), and group 2 showing an imaging pattern atypical of CCRCC. We then evaluated the association between clinicopathological characteristics and pathological diagnosis in order to identify factors which can predict the pathological diagnosis.

Results

Based on the criteria, 102 (70.8 %) and 42 (29.2 %) patients were classified into group 1 and group 2, respectively. The only independent factor identified to predict the final pathological diagnosis of the 144 patients was preoperative CT findings. Only 7 (6.9 %) patients were pathologically diagnosed with benign tumors in group 1; however, 13 (31.0 %) of the 42 patients in group 2 appeared to have pathologically confirmed benign tumors. A younger age and lower body mass index (BMI) in group 2 were shown to be independently associated with benign histology on multivariate analysis.

Conclusions

The proportion of patients with benign tumors was comparatively high in those with CT findings atypical for CCRCC; therefore, other clinical parameters, such as age and BMI, should be considered when determining therapeutic strategies for patients with such SRMs.
Literature
1.
go back to reference Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334PubMedCrossRef Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334PubMedCrossRef
2.
go back to reference Jeon HG, Lee SR, Kim KH et al (2010) Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 76:574–579PubMedCrossRef Jeon HG, Lee SR, Kim KH et al (2010) Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 76:574–579PubMedCrossRef
3.
go back to reference Kane CJ, Mallin K, Ritchey J et al (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113:78–83PubMedCrossRef Kane CJ, Mallin K, Ritchey J et al (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113:78–83PubMedCrossRef
4.
go back to reference Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740PubMedCrossRef Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740PubMedCrossRef
5.
go back to reference Dechet CB, Zincke H, Sebo TJ et al (2003) Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 169:71–74PubMedCrossRef Dechet CB, Zincke H, Sebo TJ et al (2003) Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 169:71–74PubMedCrossRef
6.
go back to reference Snyder ME, Bach A, Kattan MW et al (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2395PubMedCrossRef Snyder ME, Bach A, Kattan MW et al (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2395PubMedCrossRef
7.
go back to reference Gill IS, Matin SF, Desai MM et al (2003) Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 170:64–68PubMedCrossRef Gill IS, Matin SF, Desai MM et al (2003) Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 170:64–68PubMedCrossRef
8.
go back to reference McKiernan J, Yossepowitch O, Kattan MW et al (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009PubMedCrossRef McKiernan J, Yossepowitch O, Kattan MW et al (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009PubMedCrossRef
9.
go back to reference Murphy AM, Buck AM, Benson MC et al (2009) Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 73:1293–1297PubMedCrossRef Murphy AM, Buck AM, Benson MC et al (2009) Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 73:1293–1297PubMedCrossRef
10.
go back to reference Millet I, Doyon FC, Hoa D et al (2011) Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol 197:887–896PubMedCrossRef Millet I, Doyon FC, Hoa D et al (2011) Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol 197:887–896PubMedCrossRef
11.
go back to reference Pierorazio PM, Hyams ES, Tsai S et al (2013) Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 81:1265–1271PubMedCrossRef Pierorazio PM, Hyams ES, Tsai S et al (2013) Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 81:1265–1271PubMedCrossRef
12.
go back to reference Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef
13.
go back to reference Kim JK, Kim TK, Ahn HJ et al (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178:1499–1506PubMedCrossRef Kim JK, Kim TK, Ahn HJ et al (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178:1499–1506PubMedCrossRef
14.
go back to reference Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T et al (2004) Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol 183:1387–1391PubMedCrossRef Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T et al (2004) Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol 183:1387–1391PubMedCrossRef
Metadata
Title
Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy
Authors
Masatomo Nishikawa
Hideaki Miyake
Kazuhiro Kitajima
Satoru Takahashi
Kazuro Sugimura
Masato Fujisawa
Publication date
01-02-2015
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2015
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0673-7

Other articles of this Issue 1/2015

International Journal of Clinical Oncology 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine